FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Bid/Ask 11:09:27 24/05/2024 pm IST | After market 11:33:59 pm | |||
| 3.76 EUR | +0.53% |
|
3.855 | +2.53% |
| Current month | -32.25% | ||
| 1 month | -82.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 3.76 | +0.53% |
| 23/24/23 | 3.74 | +34.05% |
| 22/24/22 | 2.79 | +8.56% |
| 21/24/21 | 2.57 | +13.72% |
| 20/24/20 | 2.26 | -6.61% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 11:09 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462X |
| ISIN | DE000HD462X3 |
| Date issued | 27/03/2024 |
| Strike | 239.9 $ |
| Maturity | Unlimited |
| Parity | 6.4 : 1 |
| Emission price | 9.8 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 26.49 € |
|---|---|
| Lowest since issue | 1.82 € |
| Spread | 0.05 € |
| Spread % | 1.30% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.1
USD
Average target price
286.1
USD
Spread / Average Target
+31.18%
- Stock Market
- Certificates
- Certificat
